US 8207163
Compositions, synthesis, and methods of using piperazine based antipsychotic agents
granted A61PA61P25/18A61P25/24
Quick answer
US patent 8207163 (Compositions, synthesis, and methods of using piperazine based antipsychotic agents) held by REVIVA PHARMACEUTICALS, INC. expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P25/18, A61P25/24